DIANTHUS THERAPEUTICS INC
DNTHNASDAQ🏆 #1117 by market capEarnings Nov 4US Equity
$110.38▲ $1.92 (+1.74%)
Live1h▲ 0.5%
24h▲ 1.7%
7d▼ 1.7%
14d▲ 6.2%
30d▲ 11.8%
1y▲ 455.5%
🏦Market Cap
$6.17B
Small Cap
📈Revenue Growth (YoY)
-67.3%
Declining
📊Gross Margin
96.0%
High
💵FCF Margin
-8178.0%
Thin
⚖️P/S Ratio
3228.9x
Expensive
Otter Score
42
Weak
📊
Analyst Ratings
Price
$110.38
Total
11
Raised
1
Lowered
0
Avg PT
$124.18
H / L
$158 / $98
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-08-06 |
Truist Securities | Reiterated | Buy | 2026-08-06 |
Wedbush | Reiterated | Outperform | 2026-08-05 |
Evercore ISI Group | Reiterated | Outperform | 2026-08-03 |
Clear Street | Reiterated | Buy | 2026-03-10 |
Baird | Reiterated | Outperform | 2026-03-10 |
Raymond James | Upgraded | Outperform → Strong Buy | 2026-03-10 |
Oppenheimer | Reiterated | Outperform | 2026-03-09 |
Guggenheim | Reiterated | Buy | 2026-03-04 |
Jefferies | Reiterated | Buy | 2026-02-02 |
Stifel | Reiterated | Buy | 2025-09-12 |
One row per institution, most recent rating